Increase in endemic neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in england and wales

Clinical Infectious Diseases

Volumn 60, Issue 4, 2015, Pages 578-585

  Ladhani, Shamez N ^a,b   Beebeejaun, Kazim ^a   Lucidarme, Jay ^c   Campbell, Helen ^a   Gray, Steve ^c   Kaczmarski, Ed ^c   Ramsay, Mary E ^a   Borrow, Ray ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

epidemiology; meningococcal pneumonia; meningococcal W disease; ST 11 clonal complex; travel

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTHRITIS, INFECTIOUS; BACTERIAL CAPSULE; BACTERIAL GENOME; CHILD; CLASSIFICATION; DNA SEQUENCE; ENDEMIC DISEASE; EPIDEMIOLOGICAL MONITORING; FEMALE; FOLLOW UP; GENETICS; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NEISSERIA MENINGITIDIS; PHENOTYPE; PHYLOGENY; PNEUMONIA, BACTERIAL; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEPSIS; SUPRAGLOTTITIS; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARTHRITIS, INFECTIOUS; BACTERIAL CAPSULES; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; ENGLAND; EPIDEMIOLOGICAL MONITORING; FEMALE; FOLLOW-UP STUDIES; GENOME, BACTERIAL; HUMANS; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; PHENOTYPE; PHYLOGENY; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEPSIS; SEQUENCE ANALYSIS, DNA; SUPRAGLOTTITIS; WALES; YOUNG ADULT;

EID: 84922350486     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu881     Document Type: Article

References (26)

1. Halperin SA, Bettinger JA, Greenwood B, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine 2012; 30(suppl 2):B26-36.
2. Ladhani SN, Flood JS, Ramsay ME, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine 2012; 30:3710-6.
3. Isaacs D, McVernon J. Introducing a new group B meningococcus vaccine. BMJ 2014; 348:g2415.
4. Hahne SJ, Gray SJ, Jean F, et al. W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet 2002; 359:582-3.
5. Gray SJ, Trotter CL, Ramsay ME, et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol 2006; 55:887-96.
6. Jolley KA, Maiden MC. Using MLST to study bacterial variation: prospects in the genomic era. Future Microbiol 2014; 9:623-30.
7. Huson DH. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics 1998; 14:68-73.
8. Ladhani SN, Lucidarme J, Newbold LS, et al. Invasive meningococcal capsular group Y disease, England andWales, 2007-2009. Emerg Infect Dis 2012; 18:63-70.
9. Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine 2012; 30(suppl 2):B3-9.
10. Gaschignard J, Levy C, Deghmane AE, et al. Invasive serogroup w meningococcal disease in children: a national survey from 2001 to 2008 in France. Pediatr Infect Dis J 2013; 32:798-800.
11. Vienne P, Ducos-Galand M, Guiyoule A, et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis 2003; 37:1639-42.
12. Schwam E, Cox J. Fulminant meningococcal supraglottitis: an emerging infectious syndrome?. Emerg Infect Dis 1999; 5:464-7.
13. Public Health England. Guidance for public health management of meningococcal disease in the UK. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/322008/Guidance-for-management-of-meningococcal-disease-pdf.pdf. Accessed 17 November 2014.
14. von Gottberg A, du Plessis M, Cohen C, et al. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 2008; 46:377-86.
15. Weidlich L, Baethgen LF, Mayer LW, et al. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5, 2:ST-11 clone in Southern Brazil. J Infect 2008; 57:324-31.
16. Barroso DE, Castineiras TM, Cabral AC, et al. Neisseria meningitidis ST-11 clonal complex bearing capsule serogroups B, C, or W in Brazil. J Infect 2013; 66:547-50.
17. Efron AM, Sorhouet C, Salcedo C, Abad R, Regueira M, Vazquez JA. W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina. J Clin Microbiol 2009; 47:1979-80.
18. Valenzuela MT, Moreno G, Vaquero A, et al. Emergence of W135 meningococcal serogroup in Chile during 2012 [in Spanish]. Rev Med Chil 2013; 141:959-67.
19. Macneil JR, Medah I, Koussoube D, et al. Neisseria meningitidis serogroup W, Burkina Faso, 2012. Emerg Infect Dis 2014; 20: 394-9.
20. Collard JM, Issaka B, Zaneidou M, et al. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis 2013; 13:576.
21. Hossain MJ, Roca A, Mackenzie GA, et al. Serogroup W135 meningococcal disease, The Gambia, 2012. Emerg Infect Dis 2013; 19:1507-10.
22. Parent du Chatelet I, Barboza P, Taha MK. W135 invasive meningococcal infections imported from sub-Saharan Africa to France, January to April 2012. Euro Surveill 2012; 17:pii:20181.
23. Taha MK, Kacou-N'douba A, Hong E, et al. Travel-related Neisseria meningitidis serogroup W135 infection, France. Emerg Infect Dis 2013; 19:1030-2.
24. Trotter CL, Findlow H, Borrow R. Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009. Clin Vaccine Immunol 2012; 19:219-22.
25. Gasparini R, Panatto D. Meningococcal glycoconjugate vaccines. Hum Vaccin 2011; 7:170-82
26. Jolley KA, Maiden MC. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010; 11:595.